Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Similarities and differences in the oncology drug approval process between FDA and European Union with emphasis on in vitro companion diagnosticsAdrian M Senderowicz, Otmar PfaffCancer Research|April 5, 2005
RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cellsUtpal K Mukhopadhyay, Adrian M Senderowicz, Gerardo FerbeyreMolecular Carcinogenesis|April 2, 2004
Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugsAnita F W Frijhoff, Claudio J Conti, Adrian M SenderowiczMolecular Carcinogenesis|April 2, 2003
Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potentialTyler Lahusen, Adriana De Siervi, Conrad Kunick, et al.The Annals of Pharmacotherapy|April 30, 2002
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical developmentSuoping Zhai, Adrian M Senderowicz, Edward A Sausville, et al.Cancer Research|May 20, 2004
UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathwayMaria M Facchinetti, Adriana De Siervi, Doreen Toskos, et al.Cancer Research|April 19, 2005
Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1Martin F Aguero, Maria M Facchinetti, Zhanna Sheleg, et al.The Journal of Biological Chemistry|December 29, 2007
S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cellsJose L Oliva, M Cecilia Caino, Adrian M Senderowicz, et al.Oncology (Williston Park, N.Y.)|February 6, 2008
Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreasAdrian M Senderowicz, John R Johnson, Rajeshwari Sridhara, et al.Cancer Research|March 13, 2002
Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrestVyomesh Patel, Tyler Lahusen, Terence Sy, et al.Pageof 4